文献速递肺栓塞与肺血管病

中国慢性血栓栓塞性肺动脉高压患者的特征与长期生存

Characteristics and long-term survival of patients with chronic thromboembolic pulmonary hypertension in China.
PubMed 文献 · Respirology · 2020-09-20

本研究基于中国18中心前瞻性注册登记,纳入593例CTEPH患者,分别接受PEA、BPA或药物治疗,报告其特征与长期生存。全体患者1、3、5、8年估计生存率分别为95.2%、84.6%、73.4%、66.6%,PEA为生存独立预测因素。

要点

  • 中国CTEPH患者长期生存率与国际及西班牙注册登记相似。
  • PEA治疗患者8年估计生存率80.2%,高于药物治疗的64.1%。
  • PEA是全因生存的独立预测因素,其他独立危险因素包括CHD、心脏指数、PVR等。

核心结论

  • 中国CTEPH患者长期估计生存率与国际及西班牙注册登记相似。
  • PEA是CTEPH患者生存的独立预测因素。

研究设计与样本

  • 前瞻性多中心注册登记,2009年8月至2018年7月于18个中心纳入593例确诊CTEPH患者。
  • 采用Cox回归模型评估预后因素。

主要发现

  • 全体患者1、3、5、8年估计生存率分别为95.2%、84.6%、73.4%、66.6%。
  • 手术治疗患者1、3、5、8年估计生存率分别为92.6%、89.6%、87.5%、80.2%。
  • 药物治疗患者1、3、5、8年估计生存率分别为95.4%、88.3%、71.0%、64.1%。
  • BPA治疗患者1、3、5、7年估计生存率分别为96.7%、88.1%、70.0%、70.0%。
  • 全体患者中PEA为生存独立预测因素,其他独立危险因素包括CHD、心脏指数、PVR、大内皮素-1、APE和6MWD。

临床怎么用

  • 中国CTEPH患者应评估是否适合PEA,PEA与更好的长期生存相关。
  • 基线CHD、心脏指数、PVR、大内皮素-1、APE和6MWD可用于风险分层。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: The purpose of this study was to report the characteristics and long-term survival of patients with CTEPH treated in three distinct ways: PEA, BPA and medical therapy. METHODS: Patients diagnosed with CTEPH were included in the registry that was set up in 18 centres from August 2009 to July 2018. The characteristics and survival of patients with CTEPH receiving the different treatments were reported. Prognostic factors were evaluated by Cox regression model. RESULTS: A total of 593 patients with CTEPH were included. Eighty-one patients were treated with PEA, 61 with BPA and 451 with drugs. The estimated survival rates at 1, 3, 5 and 8 years were, respectively, 95.2%, 84.6%, 73.4% and 66.6% in all patients; 92.6%, 89.6%, 87.5% and 80.2% in surgical patients; and 95.4%, 88.3%, 71.0% and 64.1% in medically treated patients. The estimated survival rates at 1, 3, 5 and 7 years in patients treated with BPA were 96.7%, 88.1%, 70.0% and 70.0%, respectively. For all patients, PEA was an independent predictor of survival. Other independent risk factors were CHD, cardiac index, PVR, big endothelin-1, APE and 6MWD. CONCLUSION: This is the first multicentre prospective registry reporting baseline characteristics and estimated survival of patients with CTEPH in China. The long-term survival rates are similar to those of patients in the international and Spanish registries. PEA is an independent predictor of survival.

来源:Respirology,查看原文。版权归原作者所有。

引用

  1. Deng L, Quan R, Yang Y, et al. Characteristics and long-term survival of patients with chronic thromboembolic pulmonary hypertension in China. Respirology. 2020. PMID: 32954622. doi:10.1111/resp.13947

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。